Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | 14M | 2M | 4M | — |
| Cost of revenue | — | 1M | 20M | 9M |
| Gross profit | 4M | 437,000 | −16M | −9M |
| Research and development | — | — | 2M | 908,000 |
| Operating income | −8M | −17M | −37M | −35M |
| Pre-tax income | −1M | −14M | −31M | −27M |
| Net income | −952,000 | −14M | −31M | −27M |
| Earnings per share | −1.27 | −0.75 | −2.12 | −2.05 |
| Earnings per share, diluted | −1.27 | −0.75 | −2.12 | −2.05 |
| Metric | 19 Aug 2026 | 18 Aug 2026 | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 575,000 | 214,000 | 1M | 5M |
| Inventory | — | — | 171,000 | 1M | 4M |
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Operating cash flow | −8M | −8M | −9M | −30M |
| Depreciation and amortisation | 147,000 | 3M | 3M | 1M |
| Share-based compensation | 2M | 2M | 1M | 4M |
| Capital expenditure |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| Current assets | — | — | 6M | 7M | 11M | — |
| Property, plant and equipment | — | — | 1M | 307,000 | 25M | 21M |
| Goodwill | — | — | 7M | 19M | — | — |
| Total assets | — | — | 36M | 28M | 42M | — |
| Current liabilities | — | — | 12M | 13M | 20M | — |
| Short-term debt | — | — | 2M | 2M | 1M | — |
| Total liabilities | — | — | — | 17M | 40M | — |
| Equity | — | — | 21M | 11M | 3M | 29M |
| — |
| 11,000 |
| 9M |
| 9M |
| Investing cash flow | −456,000 | 800,000 | −1M | 25M |
| Financing cash flow | 9M | 6M | 3M | 2M |